Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Liver Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03499808
What this trial is testing

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Who this might be right for
Amorphous, Eosinophilic, and Acellular DepositConstipationDiarrhea+10 more
SWOG Cancer Research Network 43
Testing effectiveness (Phase 2)Study completedNCT00009893
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 42
Early research (Phase 1)Ended earlyNCT00003147
What this trial is testing

Gene Therapy in Treating Patients With Cancer of The Liver

Who this might be right for
Liver Cancer
National Cancer Institute (NCI) 30
Not applicableUnknownNCT05637788
What this trial is testing

Artificial Intelligence and Hepatocellular Carcinoma

Who this might be right for
HCC
Humanitas Clinical and Research Center 535
Testing effectiveness (Phase 2)Study completedNCT00554372
What this trial is testing

Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Jennerex Biotherapeutics 30
Early research (Phase 1)Study completedNCT01497444
What this trial is testing

Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney CancerLiver Cancer
Alliance for Clinical Trials in Oncology 24
Very early researchUnknownNCT04048317
What this trial is testing

Effectiveness of Drug Eluting TACE in Primary HCC

Who this might be right for
Hepatic Cell Carcinoma
Assiut University 75
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)Study completedNCT00003923
What this trial is testing

Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more
Memorial Sloan Kettering Cancer Center 4
Not applicableStudy completedNCT00822562
What this trial is testing

Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00321594
What this trial is testing

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 54
Large-scale testing (Phase 3)Study completedNCT01307878
What this trial is testing

New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases

Who this might be right for
Colorectal NeoplasmsNeoplasm MetastasisLiver Neoplasms+1 more
Fudan University 320
Not applicableStudy completedNCT02475889
What this trial is testing

Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer

Who this might be right for
Colorectal Cancer
The First People's Hospital of Changzhou 78
Large-scale testing (Phase 3)Study completedNCT01164202
What this trial is testing

Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Federation Francophone de Cancerologie Digestive 78
Post-approval studies (Phase 4)UnknownNCT02557503
What this trial is testing

Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE

Who this might be right for
Advanced Adult Primary Liver Cancer
Zhu Xu 110
Testing effectiveness (Phase 2)Ended earlyNCT02421354
What this trial is testing

Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis

Who this might be right for
HepatomegalyMyelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+2 more
M.D. Anderson Cancer Center 8
Not applicableStudy completedNCT00081094
What this trial is testing

Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer

Who this might be right for
Liver Cancer
Washington University School of Medicine 31
Not applicableUnknownNCT03166553
What this trial is testing

Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer

Who this might be right for
Advanced Primary Liver Cancer
BeiJing Yijiayi Medicine Techonoloy Co., Ltd. 150
Testing effectiveness (Phase 2)UnknownNCT06029829
What this trial is testing

The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.

Who this might be right for
Hepatocellular Carcinoma
Xin-Hua Xu 60
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Next Page